摘要
肿瘤坏死因子(TNF)超家族(TNFSF)包括有关三十个结构相关的受体(TNFSFRs)和绑定到一个或多个这些受体的大约二十个蛋白质配体。几乎所有这些细胞表面蛋白质相互作用(PPIs)代表高价值的治疗目标即自身免疫性疾病、移植受体、癌症的炎症反应和免疫调制,还有那些在临床开发的各个阶段的几种生物制剂包括抗体、融合蛋白定位。如果可以解决与小分子的蛋白质相互作用的目标相关的困难,小分子抑制剂或活化剂可以代表可能的替代品。化学合成证明了这种方法的可行性并以确定了大量的肿瘤坏死因子超家族受体-肿瘤坏死因子超家族型PPIs不同的药物研发途径包括CD40-CD40L、 BAFFR-BAFF、TRAIL-DR5和 OX40-OX40L。在此,对相应的结构、信号和药物化学方面简要综述。然而这些小分子调节剂没有到目前为止能确定似乎有足够的前景用于临床上。他们提供验证的证据表明,这些相互作用容易受到小分子调控作用的影响,可以作为识别更有效的和有选择性的备选项的出发点。
关键词: CD40,协同信号,成药性,OX40,肿瘤坏死因子。
Current Drug Targets
Title:TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Volume: 16 Issue: 4
Author(s): Yun Song and Peter Buchwald
Affiliation:
关键词: CD40,协同信号,成药性,OX40,肿瘤坏死因子。
摘要: The tumor necrosis factor (TNF) superfamily (TNFSF) contains about thirty structurally related receptors (TNFSFRs) and about twenty protein ligands that bind to one or more of these receptors. Almost all of these cell surface protein-protein interactions (PPIs) represent high-value therapeutic targets for inflammatory or immune modulation in autoimmune diseases, transplant recipients, or cancers, and there are several biologics including antibodies and fusion proteins targeting them that are in various phases of clinical development. Small-molecule inhibitors or activators could represent possible alternatives if the difficulties related to the targeting of protein-protein interactions by small molecules can be addressed. Compounds proving the feasibility of such approaches have been identified through different drug discovery approaches for a number of these TNFSFR-TNFSF type PPIs including CD40-CD40L, BAFFR-BAFF, TRAIL-DR5, and OX40-OX40L. Corresponding structural, signaling, and medicinal chemistry aspects are briefly reviewed here. While none of these small-molecule modulators identified so far seems promising enough to be pursued for clinical development, they provide proof-of-principle evidence that these interactions are susceptible to small-molecule modulation and can serve as starting points toward the identification of more potent and selective candidates.
Export Options
About this article
Cite this article as:
Yun Song and Peter Buchwald , TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation, Current Drug Targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450116666150223115628
DOI https://dx.doi.org/10.2174/1389450116666150223115628 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Current Genomics Altered Peptide Ligand Antagonism: From Immune Evasion to Immunotherapy
Drug Design Reviews - Online (Discontinued) Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases
Current Pharmaceutical Design Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies
Current Vascular Pharmacology Characterization of Regulatory T-Cells in Multiple Sclerosis Patients Treated with Interferon Beta-1a
CNS & Neurological Disorders - Drug Targets Pathophysiology of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Hepatitis C Viruss Immune Evasion Strategies
Current Immunology Reviews (Discontinued) Leptin, Immune Responses and Autoimmune Disease. Perspectives on the Use of Leptin Antagonists
Current Pharmaceutical Design Editorial: (Thematic Issue: Autoimmune diseases: What have we learned from mice?)
Current Pharmaceutical Design Possible Role of DNA Methylation in the Induction of Systemic Lupus Erythematosus
Current Rheumatology Reviews Pernicious Anemia: Fundamental and Practical Aspects in Diagnosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands
Current Drug Targets - Inflammation & Allergy Role of Leptin in the Immune System
Current Immunology Reviews (Discontinued) A Comparison of Biological Activity of B Lymphocyte Stimulator (BLyS) Antagonist Peptibodies and the Elucidation of Possible BLyS Binding Sites
Protein & Peptide Letters Modulation of Hepatocyte Apoptosis: Cross-talk Between Bile Acids and Nuclear Steroid Receptors
Current Medicinal Chemistry Mucosal Immunity - Basic Principles, Ontogeny, Cystic Fibrosis and Mucosal Vaccination
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Diabetes Mellitus: A Potential Target for Stem Cell Therapy
Current Stem Cell Research & Therapy Mesenchymal Stromal Cells in Rheumatoid Arthritis: Biological Properties and Clinical Applications
Current Stem Cell Research & Therapy An Update on JAK Inhibitors
Current Medicinal Chemistry The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry